Cannabidiol for the treatment ofcannabiswithdrawal syndrome: a case report

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

(2009) TV Zanelati et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pharmacotherapy for Cannabis Dependence

(2009) Ryan Vandrey et al.   CNS DRUGS

Cannabis and anxiety: a critical review of the evidence

(2009) José Alexandre Crippa et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor

(2008) Ziva D. Cooper et al.   ADDICTION BIOLOGY

The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent.

(2008) Eric Murillo-Rodríguez et al.   BEHAVIORAL NEUROSCIENCE

The endocannabinoid system as a target for the treatment of cannabis dependence

(2008) Jason R. Clapper et al.   NEUROPHARMACOLOGY

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA